The integration of pharmacokinetics and pharmacodynamics: Understanding dose-response

被引:41
作者
Abdel-Rahman, SM [1 ]
Kauffman, RE [1 ]
机构
[1] Univ Missouri, Childrens Mercy Hosp & Clin, Dept Pediat, Div Pediat Clin Pharmacol & Med Toxicol, Kansas City, MO 64108 USA
关键词
human pharmacology; drug biodisposition; dose-exposure relationship; exposure-response relationship;
D O I
10.1146/annurev.pharmtox.44.101802.121347
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacokinetic (PK) and pharmacodynamic (PD) studies have proven to be powerful and instructive tools, particularly in elucidating important aspects of human pharmacology. Nevertheless, they remain imperfect tools in that they only allow researchers to indirectly extrapolate, through computational modeling, the dynamic processes of drug action. Furthermore, neither tool alone provides a complete nor necessarily relevant picture of drug action. This review explores the utility and applications of PK and PD in the study of drugs, provides examples of lessons learned from their application to studies of human pharmacology, points out some of their limitations, and advances the thesis that these tools ideally should be employed together in an integrated approach. As we continue to apply these tools across the continuum of age and disease, they provide a powerful means to enhance our understanding of drug action, drug interactions, and intrinsic host factors that influence pharmacologic response.
引用
收藏
页码:111 / 136
页数:26
相关论文
共 148 条
  • [1] Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults
    Abdel-Rahman, SM
    Kearns, GL
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (06) : 613 - 618
  • [2] The bioequivalence of nizatidine (Axid®) in two extemporaneously and one commercially prepared oral liquid formulations compared with capsule
    Abdel-Rahman, SM
    Johnson, FK
    Gauthier-Dubois, G
    Weston, IE
    Kearns, GL
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (02) : 148 - 153
  • [3] Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
    Alderman, MH
    Cohen, H
    Roque, R
    Madhavan, S
    [J]. LANCET, 1997, 349 (9052) : 594 - 598
  • [4] Intestinal first pass metabolism of midazolam in liver cirrhosis - effect of grapefruit juice
    Andersen, V
    Pedersen, N
    Larsen, NE
    Sonne, J
    Larsen, S
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (02) : 120 - 124
  • [5] In vivo pharmacodynamics of a new oxazolidinone (linezolid)
    Andes, D
    van Ogtrop, ML
    Peng, J
    Craig, WA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3484 - 3489
  • [6] [Anonymous], 1989, NEW ENGL J MED, V321, P406
  • [7] DEVELOPMENTAL PATTERNS OF RENAL FUNCTIONAL MATURATION COMPARED IN HUMAN NEONATE
    ARANT, BS
    [J]. JOURNAL OF PEDIATRICS, 1978, 92 (05) : 705 - 712
  • [8] A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution
    Argenti, D
    Ireland, D
    Heald, DL
    [J]. JOURNAL OF UROLOGY, 2001, 165 (05) : 1446 - 1451
  • [9] A NOVEL PHARMACODYNAMICALLY BASED APPROACH TO DOSE OPTIMIZATION OF CARBOPLATIN WHEN USED IN COMBINATION WITH ETOPOSIDE
    BELANI, CP
    EGORIN, MJ
    ABRAMS, JS
    HIPONIA, D
    EISENBERGER, M
    AISNER, J
    VANECHO, DA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1896 - 1902
  • [10] BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368